VANCOUVER, BC — / ACCESSWIRE / — Clairvoyant Therapeutics (“Clairvoyant”) is pleased to announce that the first clinical trial participant in Finland enrolled in CLA-PSY-201 has received their first dose of… Read More
IRAK4 Program Represents the First of Up to Five Degrader Programs Within the 2019 Discovery Collaboration Agreement Nurix to Receive a $20 Million Option Fee FOSTER CITY & SAN FRANCISCO,… Read More
VANCOUVER, BC — Kardium Inc., a private medical device company that has developed the Globe® PF System for the treatment of atrial fibrillation (AF) using pulsed field ablation (PFA), announced today that… Read More
SAN DIEGO — /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that the Company will… Read More
VANCOUVER, BC — (BUSINESS WIRE) — AbCellera (Nasdaq: ABCL) today announced two upcoming poster presentations on its T-cell engager platform at the American Association for Cancer Research (AACR) Annual Meeting 2023,… Read More
